Siamak Daneshmand

35PUBLICATIONS
210CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Dec 15, 2025
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer.

John L Gore, Erika M Wolff, Michael G Nash

|Nov 18, 2025
Systemic Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder (Muscle-Invasive Bladder Cancer): Insights From Real-World Data.

Sarmad Sadeghi, Primo N Lara, Andrea Necchi

|Sep 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Andrea Necchi, Matthew D Galsky, Nazli Dizman

|Jul 30, 2025
TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.

Siamak Daneshmand, Michiel S Van der Heijden, Joseph M Jacob

|May 05, 2025
Key Updates in Testicular Cancer: Optimizing Survivorship and Survival.

Aditya Bagrodia, Hege Sagstuen Haugnes, Ragnhild Hellesnes

|Mar 13, 2025
Serum Tumor Markers for Muscle-Invasive Bladder Cancer in Clinical Practice: A Narrative Review.

Chirag Doshi, Mazyar Zahir, Anosh Dadabhoy

Pageof 6

Frequent Collaborators

7 joint publications

Alireza Ghoreifi

4 joint publications

Yair Lotan

3 joint publications

Craig Nichols

3 joint publications

Seth P Lerner